CN204188617U - A kind of H-FABP immunochromatography half-quantitative detection test paper - Google Patents
A kind of H-FABP immunochromatography half-quantitative detection test paper Download PDFInfo
- Publication number
- CN204188617U CN204188617U CN201420670682.2U CN201420670682U CN204188617U CN 204188617 U CN204188617 U CN 204188617U CN 201420670682 U CN201420670682 U CN 201420670682U CN 204188617 U CN204188617 U CN 204188617U
- Authority
- CN
- China
- Prior art keywords
- fabp
- line
- antibody
- film
- test paper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model is created and is provided a kind of H-FABP immunochromatography half-quantitative detection test paper, comprise cellulose nitrate NC film, colloidal gold pad, sample pad and thieving paper, containing H-FABP labelled antibody and rabbit igg labelled antibody in described colloidal gold pad, described cellulose nitrate NC film is being coated with detection line successively along on liquid chromatography(LC) direction, reference line and nature controlling line, the utility model is by the setting of reference line and the accurate control to line antibody content, realize carrying out half-quantitative detection to the blood serum sample of H-FABP concentration in this region of 2mg/L ~ 6.2mg/L.
Description
Technical field
The invention belongs to H-FABP detection field, and particularly a kind of colloidal gold immunity chromatography that adopts carries out the test paper of half-quantitative detection to H-FABP.
Background technology
Fatty acid binding protein (FABP) is the small molecular cell internal protein of one group of polyphyly, molecular weight 14 ~ 15kDa.The FABP found at present has 9 types, wherein heart-type FABP (H-FABP) is present in cardiac muscular tissue more specifically, also have in the parietal cell of the smooth muscle cell of red skeletal muscle, aorta wall, endothelial cell, gastric gland body and interstitial glands, be present in kidney, white skeletal muscle, adrenal gland, brain on a small quantity, but distribute without H-FABP in liver, adipose tissue.H-FABP has stable intracellular half life, about 2 ~ 3 days.
Myocardial ischemia causes myocardium cell necrosis, and H-FABP leaks into blood from cardiac muscle cell, thus makes the H-FABP in peripheral blood increase.Observe and find, it is at acute myocardial infarction AMI (acute myocardial infarction, AMI) after occurring, 1-2h raises immediately, and continue to 12h, keep higher level and higher susceptibility, in about 24h recovery and close to normal level, with myoglobins (myoglobin, Mb) similar, but because it at AMI, the abnormal rising of early stage i.e. appearance occurs, and comparatively Mb, C reactive protein (C-reaction protein, CRP) Cardiac-specific is had more, very little by other tissue effect, lot of domestic and international scholar grinds and makes internal disorder or usurp that to also demonstrate that H-FABP and myoglobins have in acute myocardial infarction (AMI) diagnosis substantially identical ageing, the Sensitivity and Specificity of diagnosis is better than Mb, current research display H-FABP has and compares Mb, CKMB, the diagnosis AMI of cTnI (T) more early stage (rear 6h appears in symptom) is worth, particularly can get rid of non-AMI patient in early days.With troponin use in conjunction, in conjunction with cardiogram and clinical symptoms, the diagnosis of emergency department to acute coronary artery syndrome (ACS) substantially can be met.
In recent years, due to the renewal of detection technique, measure quick, the easy and reliable method of H-FABP and set up rapidly, H-FABP is increased greatly in clinical practice field, its value medically is just just extensively being tested and is being admitted.
Detection method involved at present has: three classes such as euzymelinked immunosorbent assay (ELISA), immunofluorescence technique and immune colloid gold.Wherein, euzymelinked immunosorbent assay (ELISA) and these 2 kinds of methods of immunofluorescence technique detect fast, and susceptibility is high, and reagent is liquid, plug and play, and easy to use, after uncork, the term of validity is longer; Shortcoming is that reagent generally can only coordinate specialized equipment to use, and costly, this detects to be unfavorable for Grass-roots Hospital.
Immune colloidal gold technique is that phase early 1970s Faulk and Taylor firstly appears, at first for immunoelectronmicroscopy.Colloidal gold-labeled method is using collaurum as tracer label thing or developer, in a kind of Novel immune labelling technique of antigen-antibody reaction, be used successfully to now the field such as manufacture of Electronic Speculum, flow cytometer, Western blotting, protein staining, in-vitro diagnosis preparation.Current golden labelling technique often coordinates with membrane carrier, forms specific immunoassay formats, as immunity percolation test and immunity-chromatography test etc.Immuno-chromatographic test paper strip be exactly this technology for an external important development direction of examining survey mode fast, be the novel detection technique grown up on modern monoclonal antibody technique, colloidal gold immunochromatographimethod technology and new material technology basis.This technical development is in recent years rapid, clinical diagnosis particularly bedside detect and arrived widespread use, as the detection of infectious disease, early pregnancy, cancer etc. in (POCT).Immune colloidal gold technique and elisa technique belong to amynologic diagnostic method, are all the specific reactions depending on antigen and antibody, but do not need special instrument and equipment, are more suitable for scene and the other detection fast of bed.
Measure H-FABP content in serum rapidly and accurately and can play directive function for instructing community hospital quick diagnosis ACS or AMI, in great majority research, for diagnosing the H-FABP critical value of ACS and AMI to be 6.2mg/L, when the concentration of H-FABP is less than 6.2mg/L in serum, the possibility of ACS and AMI substantially can be got rid of; When the concentration of H-FABP is greater than 6.2mg/L in serum, need the possibility considering ACS and AMI.
Although having some reagent manufacturers to have developed Monitoring lower-cut is at present 0.1ng/ml, but all need to coordinate large-scale instrument just can detect, time-consuming, effort and expensive, and the detection in this region of 2mg/L ~ 6.2mg/L is often more difficult and loaded down with trivial details, be regarded as the gray area that H-FABP quantitatively detects.Therefore be badly in need of a kind of colloid gold test paper that can carry out half-quantitative detection to H-FABP in serum, to facilitate health care worker grasp conditions of patients promptly and accurately, reduce medical treatment cost.
Summary of the invention
The invention provides a kind of H-FABP immunochromatography half-quantitative detection test paper, efficiently fast and accurately semi-quantitatively detect in real time H-FABP, can have very important economy and social value.
For solving the problems of the technologies described above, the technical scheme that the invention adopts is, comprise cellulose nitrate NC film, upwards colloidal gold pad is overlapped with successively in described cellulose nitrate NC film one end, sample pad, upwards thieving paper is overlapped with at the described cellulose nitrate NC film other end, containing H-FABP labelled antibody and rabbit igg labelled antibody in described colloidal gold pad, described cellulose nitrate NC film is along liquid chromatography(LC) direction being coated with successively detection line (T line), reference line (R line) and nature controlling line (C line), described detection line is the H-FABP antibody matched with described H-FABP labelled antibody, described reference line is that goat-anti rabbit two resists, described nature controlling line is that sheep anti mouse two resists.
Wherein, described H-FABP labelled antibody is the mouse-anti people H-FABP monoclonal antibody of colloid gold label, it detection line is also mouse-anti people H-FABP monoclonal antibody with the H-FABP antibody of its pairing, the two identifies the epi-position that H-FABP is different respectively, and described rabbit igg labelled antibody is the rabbit igg antibody of colloid gold label.
Wherein, the grain size of described collaurum is 15-25nm, is preferably 20-22nm.
Wherein, after the rabbit igg labelled antibody solution of described colloidal gold pad is to be the H-FABP labelled antibody solution of 0.4-0.6 and 540nm place OD value by 540nm place OD value be 0.8-1.0 mixes with volume ratio 1: 1.5, form with the amount point sample of 2.5 μ l/mm.
Wherein, in described cellulose nitrate NC film, detection line evenly to be rule with 0.0008ml/cm by the H-FABP labelled antibody of 0.6mg/ml and is formed; Reference line evenly to be rule with 0.0008ml/cm by 1.2mg/ml goat-anti rabbit polyclonal antibody and is formed; Described nature controlling line evenly to be rule with 0.0008ml/cm by 2.0mg/ml sheep anti mouse polyclonal antibody and is formed.
Further, 0.4cm is spaced apart between described detection line (T line), reference line (R line) and nature controlling line (C line); Described colloidal gold pad, apart from being spaced apart 0.2-1.0cm between T line, is preferably 0.4-0.6cm.
Wherein, described cellulose nitrate NC film is the porous spline structure film of aperture 8-12 μm, and described sample pad is glass fibre membrane or nonwoven fabrics, and described colloidal gold pad adopts glass fibre membrane, and described thieving paper is absorbent filter, and above material is common used material, commercially available.
The advantage that the invention has and good effect are: easy to operate, be quick on the draw, susceptibility is high, be easy to carry and preserve, being applicable to medical personnel and detecting in real time.And, the present invention is by the independence setting of reference line and the accurate control to each line antibody type and content etc., realize carrying out half-quantitative detection to the blood serum sample of H-FABP concentration in this region of 2mg/L ~ 6.2mg/L, solid reference is provided for medical personnel carry out judgement to relevant diseases such as AMI, ACS, reduce medical-risk and cost, the initial stage being widely used in general hospital's bed other detection and basic hospital is fast detected.
Accompanying drawing explanation
Fig. 1 is the invention structural representation.
Fig. 2 a-2g is that the invention uses result to judge schematic diagram.
Wherein:
1-sample pad; 2-colloidal gold pad; 3-cellulose nitrate NC film; 4-T line; 5-R line; 6-C line; 7-thieving paper.
Embodiment
Be further described the invention below by specific embodiment, following detailed embodiment and concrete operating process are only the object setting forth the invention scheme, are not intended to limit the invention.
In following embodiment, the material of non-specified otherwise or reagent, be generally commercial commercially available product, or can obtain from disclosed approach via relevant healthcare institution.The experimental technique of unreceipted actual conditions and parameter in following embodiment, usually conveniently condition and parameter, or the condition of advising according to manufacturer and parameter.
The preparation of embodiment 1 collaurum
0.02% chlorauric acid solution heating is boiled, adds rapidly the trisodium citrate 2mL of 2%; Solution colour becomes dark blue from light blue, continues to add and occurs claret, continue to boil 10min; There is transparent claret, stop heating, continue to be stirred to room temperature, obtain the colloidal gold solution of particle diameter at about 20nm.Electronic Speculum microscopy, guarantee that the gold grain prepared makes it in the same size, even as far as possible, particle diameter at about 20nm, otherwise makes again.
Embodiment 2 is containing the preparation of the colloidal gold pad of labelled antibody
Get 1.5mL test tube, add 1mL colloidal gold solution; Add appropriate borate buffer solution wherein and pH is adjusted to 8.0; Add 8 μ g/mL H-FABP labelled antibodies, make it reach minimum protein concentration, mixing, quick oscillation 20min on shaker; Add the 10%BSA of 10 μ L, mixing, vibration 20min; 10000rpm in hydro-extractor, centrifugal 20min, absorbs supernatant gently; The collaurum precipitation suspending loose by 1mL wash buffer solution weight; The colloid gold immune compound that 540nm place OD (optical density) value is 0.4-0.6 is formulated in fix buffer;
Separately get 1.5mL test tube, add 1mL colloidal gold solution; Add appropriate borate buffer solution wherein and pH is adjusted to 9.0; Add 10 μ g/mL rabbit igg labelled antibodies, make it reach minimum protein concentration, mixing, quick oscillation 20min on shaker; Add the 10%BSA of 10 μ L, mixing, vibration 20min; 8000rpm in hydro-extractor, centrifugal 20min, absorbs supernatant gently; The collaurum precipitation suspending loose by 1mL wash buffer solution weight; The colloid gold immune compound that 540nm place OD (optical density) value is 0.8-1.0 is formulated in fix buffer;
The ratio of above-mentioned two kinds of colloid gold immune compounds according to volume ratio 1: 1.5 is mixed, with amount point sample on glass fibre membrane of 2.5 μ l/mm, forms colloidal gold pad, and dry under appropriate conditions, be generally 37 DEG C of dryings 12 hours.
The bag quilt of embodiment 3 cellulose nitrate NC film
Adopt spray film instrument, the H-FABP labelled antibody of 0.6mg/ml is evenly drawn with 0.0008ml/cm on cellulose nitrate NC film, forms T line; 1.2mg/ml goat-anti rabbit polyclonal antibody is evenly drawn with 0.0008ml/cm on cellulose nitrate NC film, forms R line; 2.0mg/ml sheep anti mouse polyclonal antibody is evenly drawn with 0.0008ml/cm on cellulose nitrate NC film, forms C line, and be spaced apart 0.4cm between three lines.Then drying room is put into dry under suitable temperature and humidity.
The assembling of embodiment 4 Test paper
In the hothouse that condition is suitable, the cellulose nitrate NC film that the bag that the colloidal gold pad obtain embodiment 2 and embodiment 3 obtain is done and sample pad and thieving paper are cut into suitable size, carry out bonding according to the structure shown in Fig. 1, control colloidal gold pad apart from being spaced apart 0.4-0.6cm between T line, this interval can by controlling bag by the scribing position of NC film, adjustment cutting size and bonding portion size realize, the bonding portion of colloidal gold pad and NC film is not less than 1/7 of colloidal gold pad, the bonding portion of colloidal gold pad and sample pad is 1/7 ~ 1/2 of colloidal gold pad, the bonding portion of thieving paper and NC film is not less than 1/10 of thieving paper.Above-mentioned mutually bonding each several part can in advance or bonding after be fixed on a loading plate, described loading plate can be plastic plate.Suitable size is cut to after fixedly completing.Described Test paper and then can also load one and moulds in box, and on plastic casing, counter sample pad and cellulose nitrate NC film dashed part arrange opening, are convenient for carrying and preserve.
Embodiment 5 Cleaning Principle and method
The principle of double-antibody sandwich colour developing in immunochromatographic assays is make use of in the invention, when containing certain density H-FABP in test serum, after being added sample pad, mouse source H-FABP monoclonal antibody in liquid dissolves colloidal gold pad in sample, and the mouse source H-FABP monoclonal antibody generation specific binding of H-FABP and this colloid gold label, form Ag-Ab-colloidal gold composite, and continue to move to detection line by capillary action.When sample arrives detection line, above-mentioned Ag-Ab-colloidal gold composite and the H-FABP antibody being coated on the pairing on detection line further combined with, form antibody-antigen-antibody-collaurum double-antibody sandwich compound, and assemble colour developing on detection line.Along with capillary further forward, when arriving nature controlling line, because in colloidal gold pad, H-FABP monoclonal antibody is mouse, therefore no matter in test serum whether containing H-FABP, all be fixed in the sheep anti mouse two of nature controlling line anti-catch and develop the color, namely this colour developing ensure that whole reaction system is correct.Simultaneously, the invention is in order to semiquantitative object, the rabbit IgG antibody of colloid gold label is also added in colloidal gold pad, and arrange between detection line and nature controlling line can with the anti-reference line of goat-anti rabbit two of its generation specific reaction, no matter in test serum with or without H-FABP, capital is driving rabbit igg labelled antibody to spring up forward through colloidal gold pad, and there is chromogenic reaction in reference line position, and its colour developing level is set to be equivalent to the colour developing level of H-FABP concentration when 6.2mg/L, like this, just can very easily by observing the concentration information obtaining H-FABP in test serum intuitively.Due to rabbit igg antibody there is easy acquisition, stationary phase is long, specificity good, susceptibility advantages of higher, the colour developing level under certain concentration can be played consistently when there is specific binding, and interference can not be produced to other specific reactions, therefore become the optimal selection of the invention as colour developing reference substance.
During detection, the serum sample extracted is balanced to room temperature, sample pad instills tested sample, after 5min, observes the colour developing situation of T line, R line, C line.C line develops the color, and it is identical that T line and R line go out line color, shows that in sample, H-FABP equals 6.2mg/L (see accompanying drawing 2a); C line develops the color, and T line goes out line color and is weaker than R line and goes out line color, shows the H-FABP level (see accompanying drawing 2b) between 2-6.2mg/L in sample; C line develops the color, and T line goes out line color and is better than R line and goes out line color, shows that the H-FABP in sample is greater than 6.2mg/L (see accompanying drawing 2c); C line, R line develop the color, and T line does not develop the color, and shows that the H-FABP level in sample is less than 2mg/L (see accompanying drawing 2d); C line or R line do not develop the color (see accompanying drawing 2e, 2f, 2g), show the failure of an experiment, need retest.
Claims (6)
1. a H-FABP immunochromatography half-quantitative detection test paper, comprise cellulose nitrate NC film, it is characterized in that: be upwards overlapped with colloidal gold pad successively in described cellulose nitrate NC film one end, sample pad, upwards thieving paper is overlapped with at the described cellulose nitrate NC film other end, containing H-FABP labelled antibody and rabbit igg labelled antibody in described colloidal gold pad, described cellulose nitrate NC film is along liquid chromatography(LC) direction being coated with successively detection line (T line), reference line (R line) and nature controlling line (C line), described detection line is the H-FABP antibody matched with described H-FABP labelled antibody, described reference line is that goat-anti rabbit two resists, described nature controlling line is that sheep anti mouse two resists.
2. a kind of H-FABP immunochromatography half-quantitative detection test paper according to claim 1, it is characterized in that: described H-FABP labelled antibody is the mouse-anti people H-FABP monoclonal antibody of colloid gold label, it detection line is also mouse-anti people H-FABP monoclonal antibody with the H-FABP antibody of its pairing, the two identifies the epi-position that H-FABP is different respectively, and described rabbit igg labelled antibody is the rabbit igg antibody of colloid gold label.
3. a kind of H-FABP immunochromatography half-quantitative detection test paper according to claim 2, is characterized in that: the grain size of described collaurum is 15-25nm.
4. a kind of H-FABP immunochromatography half-quantitative detection test paper according to claim 1, it is characterized in that: after the rabbit igg labelled antibody solution of described colloidal gold pad is to be the H-FABP labelled antibody solution of 0.4-0.6 and 540nm place OD value by 540nm place OD value be 0.8-1.0 mixes with volume ratio 1: 1.5, form with the amount point sample of 2.5 μ l/mm.
5. a kind of H-FABP immunochromatography half-quantitative detection test paper according to claim 1, it is characterized in that: in described cellulose nitrate NC film, detection line evenly to be rule with 0.0008ml/cm by the H-FABP labelled antibody of 0.6mg/ml and is formed; Reference line evenly to be rule with 0.0008ml/cm by 1.2mg/ml goat-anti rabbit polyclonal antibody and is formed; Described nature controlling line evenly to be rule with 0.0008ml/cm by 2.0mg/ml sheep anti mouse polyclonal antibody and is formed.
6. a kind of H-FABP immunochromatography half-quantitative detection test paper according to claim 1, is characterized in that: be spaced apart 0.4cm between described detection line, reference line and nature controlling line; Described colloidal gold pad is apart from being spaced apart 0.2-1.0cm between detection line.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420670682.2U CN204188617U (en) | 2014-11-12 | 2014-11-12 | A kind of H-FABP immunochromatography half-quantitative detection test paper |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420670682.2U CN204188617U (en) | 2014-11-12 | 2014-11-12 | A kind of H-FABP immunochromatography half-quantitative detection test paper |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204188617U true CN204188617U (en) | 2015-03-04 |
Family
ID=52620600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420670682.2U Active CN204188617U (en) | 2014-11-12 | 2014-11-12 | A kind of H-FABP immunochromatography half-quantitative detection test paper |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204188617U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113777322A (en) * | 2021-09-06 | 2021-12-10 | 珠海科域生物工程股份有限公司 | Fecal calprotectin detection kit and preparation method thereof |
-
2014
- 2014-11-12 CN CN201420670682.2U patent/CN204188617U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113777322A (en) * | 2021-09-06 | 2021-12-10 | 珠海科域生物工程股份有限公司 | Fecal calprotectin detection kit and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108254562B (en) | Detect time-resolved fluoroimmunoassay chromatograph test strip, the kit and preparation method thereof of MYO | |
| CN202794178U (en) | Fast quantitative immunochromatographic assay kit for procalcitonin | |
| CN207516379U (en) | A kind of colloidal gold immuno-chromatography test paper strip | |
| CN108267592A (en) | A kind of immune microsphere chromatography detects heparin-binding protein Test paper | |
| CN203732542U (en) | Test paper card and diagnostic kit for detecting rheumatoid arthritis | |
| CN102221612A (en) | Method for employing double indicatrix immunochromatography by semi-quantity to diagnose carcinoembryonic antigen | |
| CN103869079A (en) | Colloidal gold test paper for rapidly and quantificationally detecting galectin-3 | |
| CN101566631A (en) | Magnetic immunochromatographic test strip for combined detection of HIV-1+2 antibody and P24 antigen and preparation method thereof | |
| CN102087294A (en) | Immunochromatographic test strip for rapidly detecting malaria and preparation method thereof | |
| CN104142399A (en) | Test paper strip using colloidal gold immunochromatographic technology for quantitative determination of serum pepsinogen and preparation method and application thereof | |
| CN203101401U (en) | Procalcitonin whole blood detecting device | |
| CN102565426A (en) | Method for diagnosing luteinizing hormone (LH) in semi-quantitative mode by employing double-indicatrix immunochromatography | |
| CN204188618U (en) | A kind of DDi immunochromatography half-quantitative detection test paper | |
| CN102087285B (en) | Immunochromatographic test strip for rapidly detecting acute pancreatitis and preparation method thereof | |
| CN204188617U (en) | A kind of H-FABP immunochromatography half-quantitative detection test paper | |
| CN204188623U (en) | A kind of NT-proBNP precursor immunochromatography half-quantitative detection test paper | |
| CN207081742U (en) | A kind of ABO/Rh blood groups diagnose test card | |
| CN101738476B (en) | Rapid diagnosis kit for pre-S1 antigens of hepatitis B viruses and method for preparing same | |
| CN204188626U (en) | A kind of B-typeNatriuretic Peptide immunochromatography half-quantitative detection test paper | |
| CN101762692A (en) | Magnetic immunochromatographic strip for detection of tuberculosis (TB) antibody in blood and preparation method thereof | |
| CN203443962U (en) | Rapid detection card for mycobacterium tuberculosis antibody | |
| CN202837307U (en) | Neutrophil gelatinase-associated lipocalin (NGAL) fluorescence nano immunochromatography quantitative test strip | |
| CN110873801A (en) | Thyroid hormone immunochromatography test strip and preparation method and kit thereof | |
| CN203241420U (en) | Novel joint detection reagent | |
| CN207067142U (en) | Colloidal gold strip and detection means |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |